Skip to content

Clinical trials

Phase 3 Intellectual Disability trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intellectual Disability Phase: Phase 3 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20152
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status4
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)4
Taysha Gene Therapies, Inc.2
IRCCS Burlo Garofolo1
Merz Pharmaceuticals GmbH1
Neurogene Inc.1
Shionogi1
The George Institute1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intellectual Disability12
Nervous System Diseases4
Neurologic Manifestations4
Cerebral Palsy3
Genetic Diseases, X-Linked3
Neurodevelopmental Disorders3
Pathologic Processes3
Rett Syndrome3
Brain Injuries2
Congenital, Hereditary, and Neonatal Diseases and Abnormalities2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.